| For: | Pichai MV, Ferguson LR. Potential prospects of nanomedicine for targeted therapeutics in inflammatory bowel diseases. World J Gastroenterol 2012; 18(23): 2895-2901 [PMID: 22736912 DOI: 10.3748/wjg.v18.i23.2895] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i23/2895.htm |
| Number | Citing Articles |
| 1 |
Kat F. Kiilerich, Trine Andresen, Behrooz Darbani, Laura H. K. Gregersen, Anette Liljensøe, Tue B. Bennike, René Holm, Jesper B. Moeller, Vibeke Andersen. Advancing Inflammatory Bowel Disease Treatment by Targeting the Innate Immune System and Precision Drug Delivery. International Journal of Molecular Sciences 2025; 26(2) doi: 10.3390/ijms26020575
|
| 2 |
Dongwei Guo, JoEllyn M. McMillan, Howard E. Gendelman. Handbook of Neurotoxicity. 2014; doi: 10.1007/978-1-4614-5836-4_116
|
| 3 |
Mahira Zeeshan, Hussain Ali, Salman Khan, Saeed Ahmad Khan, Benno Weigmann. Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease. International Journal of Pharmaceutics 2019; 558 doi: 10.1016/j.ijpharm.2018.12.074
|
| 4 |
Angelo Viscido, Annalisa Capannolo, Giovanni Latella, Renzo Caprilli, Giuseppe Frieri. Nanotechnology in the treatment of inflammatory bowel diseases. Journal of Crohn's and Colitis 2014; 8(9) doi: 10.1016/j.crohns.2014.02.024
|
| 5 |
Juan C Andreu-Ballester, Rafael Gil-Borrás, Carlos García-Ballesteros, Ignacio Catalán-Serra, Victoria Amigo, Virgina Fernández-Fígares, Carmen Cuéllar. Epstein-Barr virus is related with 5-aminosalicylic acid, tonsillectomy, and CD19<sup>+</sup> cells in Crohn’s disease. World Journal of Gastroenterology 2015; 21(15): 4666-4672 doi: 10.3748/wjg.v21.i15.4666
|
| 6 |
Sumit Sharma, Vivek R. Sinha. Current pharmaceutical strategies for efficient site specific delivery in inflamed distal intestinal mucosa. Journal of Controlled Release 2018; 272 doi: 10.1016/j.jconrel.2018.01.003
|
| 7 |
Sheng Ma, Haochen Yao, Xinghui Si, Zichao Huang, Ruoyi Wang, Renming Wan, Zhaohui Tang, Guoqing Wang, Wantong Song. Orally available dextran-aspirin nanomedicine modulates gut inflammation and microbiota homeostasis for primary colorectal cancer therapy. Journal of Controlled Release 2024; 370 doi: 10.1016/j.jconrel.2024.05.002
|
| 8 |
. 2021; doi: 10.70675/84bd1d3bz2f32z4363z88d8z7ace5e2d9a79
|
| 9 |
Yongfeng Zhang, Yaqin Zhang, Yang Zhao, Wanyue Wu, Weiqi Meng, Yulin Zhou, Ye Qiu, Chenliang Li. Protection against ulcerative colitis and colorectal cancer by evodiamine via anti‑inflammatory effects. Molecular Medicine Reports 2022; 25(5) doi: 10.3892/mmr.2022.12704
|
| 10 |
Izabela B.C. Lima, Lina Clara.G.A.I. Moreno, Edson C. Silva-Filho, Juan M. Irache, Francisco J.B. Veiga, Hercília M.L. Rolim, Lívio C.C. Nunes. Development of nanostructured systems using natural polymers to optimize the treatment of inflammatory bowel diseases: A prospective study. Journal of Drug Delivery Science and Technology 2021; 64 doi: 10.1016/j.jddst.2021.102590
|
| 11 |
Mohammed N. Khan, Majella E. Lane, Paul A. McCarron, Murtaza M. Tambuwala. Caffeic acid phenethyl ester is protective in experimental ulcerative colitis via reduction in levels of pro-inflammatory mediators and enhancement of epithelial barrier function. Inflammopharmacology 2018; 26(2) doi: 10.1007/s10787-017-0364-x
|
| 12 |
Tanya P. Puchakayala, Sri Vinisha Kakarlapudi, Divya S. Parimi, Pranavi Vadla, Anand V. Kanumuri, Rohini Dasari, Salman Khan, Anil K. Suresh. Emergence of Sustainable Biomaterials in Tackling Inflammatory Diseases. Smart Nanomaterials Technology 2025; doi: 10.1007/978-981-96-2112-5_18
|
| 13 |
Sakshi Aggarwal, Prakash Haloi, Muskan Kumari Agarwal, Priyanka Saroj, Navneet Sharma, Pratap Kalita. Advances in inflammatory bowel disease (IBD): Immune mechanisms, preclinical models, and emerging therapeutic strategies. Journal of Drug Delivery Science and Technology 2026; 122 doi: 10.1016/j.jddst.2026.108420
|
| 14 |
Narenda Kumar, Rajiv Kumar. Nanotechnology and Nanomaterials in the Treatment of Life-threatening Diseases. 2014; doi: 10.1016/B978-0-323-26433-4.00007-5
|
| 15 |
Joana Torres, Silvio Danese, Jean-Frédéric Colombel. New therapeutic avenues in ulcerative colitis: thinking out of the box. Gut 2013; 62(11) doi: 10.1136/gutjnl-2012-303959
|
| 16 |
Shanshan Li, Fuzhong Zhang, Qixiong Zhang. Pathological features-based targeted delivery strategies in IBD therapy: A mini review. Biomedicine & Pharmacotherapy 2022; 151 doi: 10.1016/j.biopha.2022.113079
|
| 17 |
Federica Di Vincenzo, Ylenia Yadid, Valentina Petito, Valeria Emoli, Letizia Masi, Daniela Gerovska, Marcos Jesus Araúzo-Bravo, Antonio Gasbarrini, Birgitte Regenberg, Franco Scaldaferri. Circular and Circulating DNA in Inflammatory Bowel Disease: From Pathogenesis to Potential Molecular Therapies. Cells 2023; 12(15) doi: 10.3390/cells12151953
|
| 18 |
Nidhi Mishra, Samipta Singh, Priyanka Maurya, Raquibun Nisha, Shubhini A. Saraf. Nanoformulations in Human Health. 2020; doi: 10.1007/978-3-030-41858-8_7
|
| 19 |
Danish J. Malik, Ilya J. Sokolov, Gurinder K. Vinner, Francesco Mancuso, Salvatore Cinquerrui, Goran T. Vladisavljevic, Martha R.J. Clokie, Natalie J. Garton, Andrew G.F. Stapley, Anna Kirpichnikova. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy. Advances in Colloid and Interface Science 2017; 249 doi: 10.1016/j.cis.2017.05.014
|
| 20 |
Zhou Zhang, Chenxin Wang, Jinhao Zhang, Fangqian Wang, Xiaohua Yu, Liangliang Yu. From bench to bowel: translating targeted drug delivery through gastrointestinal barriers. Frontiers in Bioengineering and Biotechnology 2026; 14 doi: 10.3389/fbioe.2026.1763085
|
| 21 |
Shaoxin Wang, Jiang Pu, Na Li, Chuanfeng Li, Chao Li, Lan Yu, Xiaohui Wang, Shanfeng Fu, Lihong Cui. CUEDC2 Protects Against Experimental Colitis and Suppresses Excessive Proliferation of Intestinal Mucosa. Digestive Diseases and Sciences 2015; 60(12) doi: 10.1007/s10620-015-3800-z
|
| 22 |
Hicheme Hadji, Kawthar Bouchemal. Advances in the treatment of inflammatory bowel disease: Focus on polysaccharide nanoparticulate drug delivery systems. Advanced Drug Delivery Reviews 2022; 181 doi: 10.1016/j.addr.2021.114101
|
| 23 |
Limei Zhou, Yunxia Shang, Yaru Wang, Xiaohui Wei. Transferrin modified PEG–PLGA nanoparticles: highly effective notoginsenoside R1 formulations for the treatment of ulcerative colitis. Journal of Pharmaceutical Investigation 2024; 54(3) doi: 10.1007/s40005-023-00657-4
|
| 24 |
Shaoxin Wang, Jiang Pu, Xiaowei Li, Zhihui Yan, Chao Li, Yan Zheng, Zhe Luo, Lihong Cui. UBE2W Improves the Experimental Colitis by Inhibiting the NF-κB Signaling Pathway. Digestive Diseases and Sciences 2022; 67(12) doi: 10.1007/s10620-022-07453-4
|
| 25 |
Panpan Ma, Xiaoying Si, Qiubing Chen, Lijun Ma, Meili Hou, Zhigang Xu, Yuejun Kang, Jianglin Wang, Bo Xiao. Oral Drug Delivery Systems for Ulcerative Colitis Therapy: A Comparative Study with Microparticles and Nanoparticles. Current Cancer Drug Targets 2019; 19(4) doi: 10.2174/1568009618666181016152042
|
| 26 |
Konstantinos H Katsanos, Konstantinos A Papadakis. Pharmacogenetics of Inflammatory Bowel Disease. Pharmacogenomics 2014; 15(16) doi: 10.2217/pgs.14.154
|
| 27 |
Maia Merabishvili, Jean-Paul Pirnay, Kilian Vogele, Danish J. Malik. Phage Therapy: A Practical Approach. 2019; doi: 10.1007/978-3-030-26736-0_1
|
| 28 |
Yao Lv, Changjun Zhen, Ana Liu, Yudie Hu, Gan Yang, Cuifang Xu, Yue Lou, Qi Cheng, Youyou Luo, Jindan Yu, Youhong Fang, Hong Zhao, Kerong Peng, Yu Yu, Jingan Lou, Jie Chen, Yan Ni, Promi Das, Peng Xu, Zhao Yicheng, Susanta Chatterjee. Profiles and interactions of gut microbiome and intestinal microRNAs in pediatric Crohn’s disease. mSystems 2024; 9(9) doi: 10.1128/msystems.00783-24
|
| 29 |
Fengqian Chen, Qi Liu, Yang Xiong, Li Xu. Current Strategies and Potential Prospects of Nanomedicine-Mediated Therapy in Inflammatory Bowel Disease. International Journal of Nanomedicine 2021; doi: 10.2147/IJN.S310952
|
| 30 |
Shatadal Ghosh, Sumit Ghosh, Parames C. Sil. Role of nanostructures in improvising oral medicine. Toxicology Reports 2019; 6 doi: 10.1016/j.toxrep.2019.04.004
|
| 31 |
Remya Sreedhar, Somasundaram Arumugam, Rajarajan A. Thandavarayan, Vijayasree V. Giridharan, Vengadeshprabhu Karuppagounder, Vigneshwaran Pitchaimani, Rejina Afrin, Meilei Harima, Takashi Nakamura, Kazuyuki Ueno, Masahiko Nakamura, Kenji Suzuki, Kenichi Watanabe. Toki-shakuyaku-san, a Japanese kampo medicine, reduces colon inflammation in a mouse model of acute colitis. International Immunopharmacology 2015; 29(2) doi: 10.1016/j.intimp.2015.08.029
|
| 32 |
Ole Haagen Nielsen. New Strategies for Treatment of Inflammatory Bowel Disease. Frontiers in Medicine 2014; 1 doi: 10.3389/fmed.2014.00003
|
| 33 |
Bomy Lee Chung, Michael J. Toth, Nazila Kamaly, Yoshitaka J. Sei, Jacob Becraft, Willem J.M. Mulder, Zahi A. Fayad, Omid C. Farokhzad, YongTae Kim, Robert Langer. Nanomedicines for endothelial disorders. Nano Today 2015; 10(6) doi: 10.1016/j.nantod.2015.11.009
|
| 34 |
Susan Hua, Ellen Marks, Jennifer J. Schneider, Simon Keely. Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: Selective targeting to diseased versus healthy tissue. Nanomedicine: Nanotechnology, Biology and Medicine 2015; 11(5) doi: 10.1016/j.nano.2015.02.018
|
| 35 |
Arivarasu N. Anbazhagan, Mentor Thaqi, Shubha Priyamvada, Dulari Jayawardena, Anoop Kumar, Tarunmeet Gujral, Ishita Chatterjee, Edurne Mugarza, Seema Saksena, Hayat Onyuksel, Pradeep K. Dudeja. GLP-1 nanomedicine alleviates gut inflammation. Nanomedicine: Nanotechnology, Biology and Medicine 2017; 13(2) doi: 10.1016/j.nano.2016.08.004
|
| 36 |
Eden Mariam Jacob, Ankita Borah, Sindhu C Pillai, D. Sakthi Kumar. Inflammatory Bowel Disease: The Emergence of New Trends in Lifestyle and Nanomedicine as the Modern Tool for Pharmacotherapy. Nanomaterials 2020; 10(12) doi: 10.3390/nano10122460
|
| 37 |
Shangwen Zhang, Li Kang, Sheng Hu, Jie Hu, Yanping Fu, Yan Hu, Xinzhou Yang. Carboxymethyl chitosan microspheres loaded hyaluronic acid/gelatin hydrogels for controlled drug delivery and the treatment of inflammatory bowel disease. International Journal of Biological Macromolecules 2021; 167 doi: 10.1016/j.ijbiomac.2020.11.117
|
| 38 |
Nidhi Mishra, Shubhini A. Saraf. Nanocarriers Based Colon Targeting. 2025; doi: 10.1016/B978-0-443-24806-1.00005-4
|
| 39 |
F. Talaei, F. Atyabi, M. Azhdarzadeh, R. Dinarvand, A. Saadatzadeh. Overcoming therapeutic obstacles in inflammatory bowel diseases: A comprehensive review on novel drug delivery strategies. European Journal of Pharmaceutical Sciences 2013; 49(4) doi: 10.1016/j.ejps.2013.04.031
|
| 40 |
Nithin B Boppana, Asokan Devarajan, Kaliappan Gopal, Muttiah Barathan, Sazaly A Bakar, Esaki M Shankar, Abdul S Ebrahim, Shukkur M Farooq. Blockade of CXCR2 signalling: A potential therapeutic target for preventing neutrophil-mediated inflammatory diseases. Experimental Biology and Medicine 2014; 239(5) doi: 10.1177/1535370213520110
|
| 41 |
Yue Hu, Meng Li, Bin Lu, Xi Wang, Chaoying Chen, Meng Zhang. Corticotropin-releasing factor augments LPS-induced immune/inflammatory responses in JAWSII cells. Immunologic Research 2016; 64(2) doi: 10.1007/s12026-015-8740-3
|